Malignant Melanoma: Medical and Surgical Management |
Contents
Epidemiology of Melanoma | 1 |
Biology of Melanoma Differentiation and Progression | 9 |
Immunology of Melanoma | 27 |
Copyright | |
30 other sections not shown
Common terms and phrases
Acad activity adjuvant Ann Surg anoma antigens Arch Dermatol atypical benign blue nevus Cancer Res cellular chemotherapy chromosome cisplatin Clin Oncol clinical cutaneous malignant melanoma cutaneous melanoma cytotoxic dacarbazine dermis detected diagnosis differentiation disease dose drug DTIC dysplastic nevus effect ELND exposure expression FAMMM FAMMM syndrome ganglioside gene genetic growth factor histologic immune immunotherapy interferon interleukin-2 isolation perfusion lesions Levamisole limb lymph node dissection lymphocytes malignant mel malignant melanoma mela melanin melanocytes melanoma cell lines melanoma patients melphalan metastases metastatic melanoma mg/mē monoclonal antibodies mucosal melanoma mutation Natl nevi nevomelanocytic noma oncogene Pathol percent phase Pigment Cell primary melanoma Proc prognostic factors protein radiation radiotherapy randomized receptor recurrence regional lymph nodes regression reported resection response rate risk skin stage suppressor surgery surgical survival syndrome tamoxifen therapy tients tion tissue toxicity treated treatment trial tumor cells tumor thickness uveal melanoma vitro